The body that recommends what drugs can and cannot be paid for now says a drug once hailed as a breakthrough is not "cost effective".
A man from Lincolnshire who won his fight against prostate cancer has joined the ranks of those calling for Arbiraterone to remain available:
More top news
James Yorke looks at the positions Hull City still need to strengthen before the transfer window closes.
Some sunshine, frequent showers
Emma Jesson has our Bank Holiday Monday evening forecast